Qinqin Zha is a Senior Scientist at NeoGenomics, where she works as a scientific affairs scientist, focusing on NeoGenomics’ molecular and Immunoassay services. She completed her PhD at Peking University studying Alzheimer’s Disease (AD) beta amyloid precursor protein proteolysis and AD molecular genetics. She did her postdoctoral training in UC Irvine. Before she joined Neo, she worked for a companion diagnostic company where she was responsible for development of several high complexity CLIA molecular diagnostic assays for clinical trials. Her expertise is wide ranging and spans assay development/validation, cancer biology, protein biochemistry, molecular biology, genomics, molecular diagnostics, and companion diagnostics.
Qinqin Zha, PhD
Scientific Affairs, Senior Scientist